Doctor and patient awareness of treatment options for cervical intraepithelial neoplasia 1 (CIN 1): a survey questionnaire approach

Hyun Woong Cho, Soo Young Kim, Youn Ji Lee, Yung Taek Ouh, Kyung Jin Min, Sang Hoon Lee, Jin Hwa Hong, Jae Yun Song, Nak Woo Lee, Jae Kwan Lee

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The purpose of this study was to investigate doctors’ and patients’ perceptions of cervical intraepithelial neoplasia 1 (CIN 1) and its treatment methods. A survey questionnaire was offered to obstetrics and gynaecology doctors and patients with CIN 1 in 2017. Only 43% of patients knew of this disease. Regarding perceptions of its aetiology, 64% of the patients perceived human papillomavirus infection to be the main cause of CIN 1. Patients’ most preferred treatments were medication (20%), followed by alternative treatment (14%). Among doctors, regular follow-up was the most preferred method for managing CIN 1. The survey showed that current treatment modalities for CIN 1 were satisfactory to only half of doctors (50%) and patients (53%). Overall, 70% of doctors responded that new drug development for CIN 1 is needed. Although, CIN 1 is a low-grade lesion, doctors and patients expressed the desire for new therapeutic agents to manage it.IMPACT STATEMENTWhat is already known on this subject? In general, treatment is not recommended for CIN 1 because lesions are considered indicative of transient HPV infection and spontaneously regress in most patients. What do the results of this study add? Regular follow-up for CIN 1 were satisfactory to only half of doctors and patients. Thirty-six percent of patients wanted active treatment instead of regular follow-up. In addition, 70% of doctors responded that new drug development for CIN 1 is needed. What are the implications of these findings for clinical practice and/or further research? Our results support the need for therapeutic agents for CIN 1.

Original languageEnglish
JournalJournal of Obstetrics and Gynaecology
DOIs
Publication statusAccepted/In press - 2019 Jan 1

Fingerprint

Cervical Intraepithelial Neoplasia
Therapeutics
Surveys and Questionnaires
Papillomavirus Infections
Gynecology
Pharmaceutical Preparations
Obstetrics

Keywords

  • Cervical intraepithelial neoplasia 1
  • doctors
  • patients
  • questionnaire
  • survey
  • treatment

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Doctor and patient awareness of treatment options for cervical intraepithelial neoplasia 1 (CIN 1) : a survey questionnaire approach. / Cho, Hyun Woong; Kim, Soo Young; Lee, Youn Ji; Ouh, Yung Taek; Min, Kyung Jin; Lee, Sang Hoon; Hong, Jin Hwa; Song, Jae Yun; Lee, Nak Woo; Lee, Jae Kwan.

In: Journal of Obstetrics and Gynaecology, 01.01.2019.

Research output: Contribution to journalArticle

@article{db59e1e12e0341aeb0db0f8581bfa8a8,
title = "Doctor and patient awareness of treatment options for cervical intraepithelial neoplasia 1 (CIN 1): a survey questionnaire approach",
abstract = "The purpose of this study was to investigate doctors’ and patients’ perceptions of cervical intraepithelial neoplasia 1 (CIN 1) and its treatment methods. A survey questionnaire was offered to obstetrics and gynaecology doctors and patients with CIN 1 in 2017. Only 43{\%} of patients knew of this disease. Regarding perceptions of its aetiology, 64{\%} of the patients perceived human papillomavirus infection to be the main cause of CIN 1. Patients’ most preferred treatments were medication (20{\%}), followed by alternative treatment (14{\%}). Among doctors, regular follow-up was the most preferred method for managing CIN 1. The survey showed that current treatment modalities for CIN 1 were satisfactory to only half of doctors (50{\%}) and patients (53{\%}). Overall, 70{\%} of doctors responded that new drug development for CIN 1 is needed. Although, CIN 1 is a low-grade lesion, doctors and patients expressed the desire for new therapeutic agents to manage it.IMPACT STATEMENTWhat is already known on this subject? In general, treatment is not recommended for CIN 1 because lesions are considered indicative of transient HPV infection and spontaneously regress in most patients. What do the results of this study add? Regular follow-up for CIN 1 were satisfactory to only half of doctors and patients. Thirty-six percent of patients wanted active treatment instead of regular follow-up. In addition, 70{\%} of doctors responded that new drug development for CIN 1 is needed. What are the implications of these findings for clinical practice and/or further research? Our results support the need for therapeutic agents for CIN 1.",
keywords = "Cervical intraepithelial neoplasia 1, doctors, patients, questionnaire, survey, treatment",
author = "Cho, {Hyun Woong} and Kim, {Soo Young} and Lee, {Youn Ji} and Ouh, {Yung Taek} and Min, {Kyung Jin} and Lee, {Sang Hoon} and Hong, {Jin Hwa} and Song, {Jae Yun} and Lee, {Nak Woo} and Lee, {Jae Kwan}",
year = "2019",
month = "1",
day = "1",
doi = "10.1080/01443615.2019.1606180",
language = "English",
journal = "Journal of Obstetrics and Gynaecology",
issn = "0144-3615",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Doctor and patient awareness of treatment options for cervical intraepithelial neoplasia 1 (CIN 1)

T2 - a survey questionnaire approach

AU - Cho, Hyun Woong

AU - Kim, Soo Young

AU - Lee, Youn Ji

AU - Ouh, Yung Taek

AU - Min, Kyung Jin

AU - Lee, Sang Hoon

AU - Hong, Jin Hwa

AU - Song, Jae Yun

AU - Lee, Nak Woo

AU - Lee, Jae Kwan

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The purpose of this study was to investigate doctors’ and patients’ perceptions of cervical intraepithelial neoplasia 1 (CIN 1) and its treatment methods. A survey questionnaire was offered to obstetrics and gynaecology doctors and patients with CIN 1 in 2017. Only 43% of patients knew of this disease. Regarding perceptions of its aetiology, 64% of the patients perceived human papillomavirus infection to be the main cause of CIN 1. Patients’ most preferred treatments were medication (20%), followed by alternative treatment (14%). Among doctors, regular follow-up was the most preferred method for managing CIN 1. The survey showed that current treatment modalities for CIN 1 were satisfactory to only half of doctors (50%) and patients (53%). Overall, 70% of doctors responded that new drug development for CIN 1 is needed. Although, CIN 1 is a low-grade lesion, doctors and patients expressed the desire for new therapeutic agents to manage it.IMPACT STATEMENTWhat is already known on this subject? In general, treatment is not recommended for CIN 1 because lesions are considered indicative of transient HPV infection and spontaneously regress in most patients. What do the results of this study add? Regular follow-up for CIN 1 were satisfactory to only half of doctors and patients. Thirty-six percent of patients wanted active treatment instead of regular follow-up. In addition, 70% of doctors responded that new drug development for CIN 1 is needed. What are the implications of these findings for clinical practice and/or further research? Our results support the need for therapeutic agents for CIN 1.

AB - The purpose of this study was to investigate doctors’ and patients’ perceptions of cervical intraepithelial neoplasia 1 (CIN 1) and its treatment methods. A survey questionnaire was offered to obstetrics and gynaecology doctors and patients with CIN 1 in 2017. Only 43% of patients knew of this disease. Regarding perceptions of its aetiology, 64% of the patients perceived human papillomavirus infection to be the main cause of CIN 1. Patients’ most preferred treatments were medication (20%), followed by alternative treatment (14%). Among doctors, regular follow-up was the most preferred method for managing CIN 1. The survey showed that current treatment modalities for CIN 1 were satisfactory to only half of doctors (50%) and patients (53%). Overall, 70% of doctors responded that new drug development for CIN 1 is needed. Although, CIN 1 is a low-grade lesion, doctors and patients expressed the desire for new therapeutic agents to manage it.IMPACT STATEMENTWhat is already known on this subject? In general, treatment is not recommended for CIN 1 because lesions are considered indicative of transient HPV infection and spontaneously regress in most patients. What do the results of this study add? Regular follow-up for CIN 1 were satisfactory to only half of doctors and patients. Thirty-six percent of patients wanted active treatment instead of regular follow-up. In addition, 70% of doctors responded that new drug development for CIN 1 is needed. What are the implications of these findings for clinical practice and/or further research? Our results support the need for therapeutic agents for CIN 1.

KW - Cervical intraepithelial neoplasia 1

KW - doctors

KW - patients

KW - questionnaire

KW - survey

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=85067393829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067393829&partnerID=8YFLogxK

U2 - 10.1080/01443615.2019.1606180

DO - 10.1080/01443615.2019.1606180

M3 - Article

C2 - 31475593

AN - SCOPUS:85067393829

JO - Journal of Obstetrics and Gynaecology

JF - Journal of Obstetrics and Gynaecology

SN - 0144-3615

ER -